132 related articles for article (PubMed ID: 32385370)
1. Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer.
Nair-Shalliker V; Bang A; Egger S; Clements M; Gardiner RA; Kricker A; Seibel MJ; Chambers SK; Kimlin MG; Armstrong BK; Smith DP
Sci Rep; 2020 May; 10(1):7736. PubMed ID: 32385370
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Fang F; Kasperzyk JL; Shui I; Hendrickson W; Hollis BW; Fall K; Ma J; Gaziano JM; Stampfer MJ; Mucci LA; Giovannucci E
PLoS One; 2011 Apr; 6(4):e18625. PubMed ID: 21494639
[TBL] [Abstract][Full Text] [Related]
3. Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men.
Meyer HE; Støer NC; Samuelsen SO; Blomhoff R; Robsahm TE; Brustad M; Giovannucci EL; Bjørge T
PLoS One; 2016; 11(3):e0151441. PubMed ID: 26986958
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
5. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
6. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
7. Association among plasma 1,25(OH)
Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
[TBL] [Abstract][Full Text] [Related]
8. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.
Dobnig H; Pilz S; Scharnagl H; Renner W; Seelhorst U; Wellnitz B; Kinkeldei J; Boehm BO; Weihrauch G; Maerz W
Arch Intern Med; 2008 Jun; 168(12):1340-9. PubMed ID: 18574092
[TBL] [Abstract][Full Text] [Related]
9. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
[TBL] [Abstract][Full Text] [Related]
10. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
[TBL] [Abstract][Full Text] [Related]
11. Plasma 25-Hydroxyvitamin D Concentrations Are Inversely Associated with All-Cause Mortality among a Prospective Cohort of Chinese Adults Aged ≥80 Years.
Mao C; Li FR; Yin ZX; Lv YB; Luo JS; Yuan JQ; Mhungu F; Wang JN; Shi WY; Zhou JH; Chen GC; Gao X; Kraus VB; Wu XB; Shi XM
J Nutr; 2019 Jun; 149(6):1056-1064. PubMed ID: 30949685
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.
Holt SK; Kolb S; Fu R; Horst R; Feng Z; Stanford JL
Cancer Epidemiol; 2013 Oct; 37(5):666-70. PubMed ID: 23972671
[TBL] [Abstract][Full Text] [Related]
13. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
Schmutz EA; Zimmermann MB; Rohrmann S
Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
[TBL] [Abstract][Full Text] [Related]
14. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
[TBL] [Abstract][Full Text] [Related]
15. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
Travis RC; Perez-Cornago A; Appleby PN; Albanes D; Joshu CE; Lutsey PL; Mondul AM; Platz EA; Weinstein SJ; Layne TM; Helzlsouer KJ; Visvanathan K; Palli D; Peeters PH; Bueno-de-Mesquita B; Trichopoulou A; Gunter MJ; Tsilidis KK; Sánchez MJ; Olsen A; Brenner H; Schöttker B; Perna L; Holleczek B; Knekt P; Rissanen H; Yeap BB; Flicker L; Almeida OP; Wong YYE; Chan JM; Giovannucci EL; Stampfer MJ; Ursin G; Gislefoss RE; Bjørge T; Meyer HE; Blomhoff R; Tsugane S; Sawada N; English DR; Eyles DW; Heath AK; Williamson EJ; Manjer J; Malm J; Almquist M; Marchand LL; Haiman CA; Wilkens LR; Schenk JM; Tangen CM; Black A; Cook MB; Huang WY; Ziegler RG; Martin RM; Hamdy FC; Donovan JL; Neal DE; Touvier M; Hercberg S; Galan P; Deschasaux M; Key TJ; Allen NE
Cancer Res; 2019 Jan; 79(1):274-285. PubMed ID: 30425058
[TBL] [Abstract][Full Text] [Related]
16. Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP.
Steck SE; Arab L; Zhang H; Bensen JT; Fontham ET; Johnson CS; Mohler JL; Smith GJ; Su JL; Trump DL; Woloszynska-Read A
PLoS One; 2015; 10(4):e0125151. PubMed ID: 25919866
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
Brändstedt J; Almquist M; Manjer J; Malm J
Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
[TBL] [Abstract][Full Text] [Related]
18. Circulating 25-hydroxyvitamin D concentration and cause-specific mortality in the Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Kvaskoff D; Eyles DW; Giles GG; English DR; Williamson EJ
J Steroid Biochem Mol Biol; 2020 Apr; 198():105612. PubMed ID: 32007563
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.
Jacobs ET; Giuliano AR; Martínez ME; Hollis BW; Reid ME; Marshall JR
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):533-7. PubMed ID: 15225833
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Freedman DM; Chang SC; Falk RT; Purdue MP; Huang WY; McCarty CA; Hollis BW; Graubard BI; Berg CD; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):889-94. PubMed ID: 18381472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
